HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE

Annals of the Rheumatic Diseases

Volumn 73, Issue 10, 2014, Pages 1888-1897

  Caza, Tiffany N ^a   Fernandez, David R ^a   Talaber, Gergely ^a   Oaks, Zachary ^a   Haas, Mark ^b   Madaio, Michael P ^c   Lai, Zhi Wei ^a   Miklossy, Gabriella ^a   Singh, Ram R ^d   Chudakov, Dmitriy M ^e   Malorni, Walter ^f   Middleton, Frank ^a   Banki, Katalin ^a   Perl, Andras ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2-(3-PYRIDINYL)-1-HYDROXYETHYLIDENE-1,1-PHOSPHONOCARBOXYLIC ACID; BISPHOSPHONIC ACID DERIVATIVE; DNM1L PROTEIN, HUMAN; DNM1L PROTEIN, MOUSE; DYNAMIN; GUANOSINE TRIPHOSPHATASE; MICROTUBULE ASSOCIATED PROTEIN; MITOCHONDRIAL PROTEIN; PYRIDINE DERIVATIVE; RAB PROTEIN;

ANIMAL; AUTOPHAGY; BLOOD; CASE CONTROL STUDY; CELL CULTURE; FEMALE; HOMEOSTASIS; HUMAN; IMMUNOLOGY; JURKAT CELL LINE; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYSOSOME; METABOLISM; MITOCHONDRION; MITOPHAGY; MOLECULARLY TARGETED THERAPY; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; PHYSIOLOGY; PROCEDURES; T LYMPHOCYTE;

ANIMALS; AUTOPHAGY; CASE-CONTROL STUDIES; CELLS, CULTURED; DIPHOSPHONATES; DYNAMINS; FEMALE; GTP PHOSPHOHYDROLASES; HOMEOSTASIS; HUMANS; JURKAT CELLS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYSOSOMES; MICE, INBRED MRL LPR; MICROTUBULE-ASSOCIATED PROTEINS; MITOCHONDRIA; MITOCHONDRIAL DEGRADATION; MITOCHONDRIAL PROTEINS; MOLECULAR TARGETED THERAPY; PYRIDINES; RAB4 GTP-BINDING PROTEINS; T-LYMPHOCYTES;

EID: 84881126185     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-203794     Document Type: Article

References (42)

1. Gergely PJ, Grossman C, Niland B, et al. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arth Rheum 2002;46:175-90.
2. Perl A, Gergely P Jr., Nagy G, et al. Mitochondrial hyperpolarization: a checkpoint of T cell life, death, and autoimmunity. Trends Immunol 2004;25:360-7.
3. Perl A. Systems biology of lupus: Mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment. Autoimmunity 2010;43:32-47.
4. Desai BN, Myers BR, Schreiber SL. FKBP12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction. Proc Natl Acad Sci USA 2002;99:4319-24.
5. Fernandez DR, Telarico T, Bonilla E, et al. Activation of mTOR controls the loss of TCR. in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation. J Immunol 2009;182:2063-73.
6. Warner LM, Adams LM, Sehgal SN. Rapamycin prolongs survival and arrests pathophysiologic changes in murine systemic lupus erythematosus. Arth Rheum 1994;37:289-97.
7. Fernandez D, Bonilla E, Mirza N, et al. Rapamycin reduces disease activity and normalizes T-cell activation-induced calcium fluxing in patients with systemic lupus erythematosus. Arth Rheum 2006;54:2983-8.
8. Lai Z-W, Hanczko R, Bonilla E, et al. N-acetylcysteine reduces disease activity by blocking mTOR in T cells of lupus patients. Arth Rheum 2012;64:2937-46.
9. Enyedy EJ, Nambiar MP, Liossis SN, et al. Fc epsilon receptor type I gamma chain replaces the deficient T cell receptor zeta chain in T cells of patients with systemic lupus erythematosus. Arth Rheum 2001;44:1114-21.
10. Sancak Y, Peterson TR, Shaul YD, et al. The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1. Science 2008;320:1496-501.
11. Magistrelli C, Samoilova E, Agarwal RK, et al. Polymorphic genotypes of the HRES-1 human endogenous retrovirus locus correlate with systemic lupus erythematosus and autoreactivity. Immunogenetics 1999;49:829-34.
12. Pullmann R Jr, Bonilla E, Phillips PE, et al. Haplotypes of the HRES-1 endogenous retrovirus are associated with development and disease manifestations of systemic lupus erythematosus. Arth Rheum 2008;58:532-40.
13. Nagy G, Ward J, Mosser DD, et al. Regulation of CD4 Expression via Recycling by HRES-1/RAB4 Controls Susceptibility to HIV Infection. J Biol Chem 2006;281:34574-91.
14. Tsao BP. Lupus susceptibility genes on human chromosome 1. Int Rev Immunol 2000;19:319-34.
15. Sengupta S, Peterson TR, Sabatini DM. Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and Stress. Mol Cell 2010;40:310-22.
16. Tooze SA, Jefferies HBJ, Kalie E, et al. Trafficking and signaling in mammalian autophagy. IUBMB Life 2010;62:503-8.
17. Weidberg H, Shvets E, Elazar Z. Biogenesis and Cargo Selectivity of Autophagosomes. Ann Rev Biochem 2011;80:125-56.
18. Chen Y, Klionsky DJ. The regulation of autophagy-unanswered questions. J Cell Sci 2011;124:161-70.
19. Gomes LC, Benedetto GD, Scorrano L. During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat Cell Biol 2011;13:589-98.
20. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arth Rheum 1982;25:1271-7.
21. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arth Rheum 1997;40:1725.
22. Perl A, Gonzalez-Cabello R, Lang I, et al. Effector activity of OKT4+ and OKT8+ T-cell subsets in lectin-dependent cell-mediated cytotoxicity against adherent HEp-2 cells. Cell Immunol 1984;84:185-93.
23. Ishihara N, Nomura M, Jofuku A, et al. Mitochondrial fission factor Drp1 is essential for embryonic development and synapse formation in mice. Nat Cell Biol 2009;11:958-66.
24. Eggers CT, Schafer JC, Goldenring JR, et al. D-AKAP2 interacts with Rab4 and Rab11 through its RGS domains and regulates transferrin receptor recycling. J Biol Chem 2009;284:32869-80.
25. Mizushima N, Yoshimori T, Levine B. Methods in Mammalian Autophagy Research. Cell 2010;140:313-26.
26. Nagy G, Barcza M, Gonchoroff N, et al. Nitric Oxide-Dependent Mitochondrial Biogenesis Generates Ca2+ Signaling Profile of Lupus T Cells. J Immunol 2004;173:3676-83.
27. Hubbard VM, Valdor R, Patel B, et al. Macroautophagy regulates energy metabolism during effector T cell activation. J Immunol 2010;185:7349-57.
28. Peng SL. Experimental use of murine lupus models. In: Perl A. ed. Methods in molecular medicine: autoimmunity methods and protocols. Totowa: Humana, 2005:227-72.
29. Kono DH, Theofilopoulos AN. Genetics of systemic autoimmunity in mouse models of lupus. [Review] [84 refs]. Int Rev Immunol 2000;19:367-87.
30. Lawson MA, Coulton L, Ebetino FH, et al. Geranylgeranyl transferase type II inhibition prevents myeloma bone disease. Biochem Biophys Res Commun 2008;377:453-7.
31. Yang SB, Lee H, Young D, et al. Rapamycin induces glucose intolerance in mice by reducing islet mass, insulin content, and insulin sensitivity. J Mol Med 2012;90:575-85.
32. Wang Y, Camirand G, Lin Y, et al. Regulatory T cells require mammalian target of rapamycin signaling to maintain both homeostasis and alloantigen-driven proliferation in lymphocyte-replete mice. J Immunol 2011;186:2809-18.
33. Huynh H, Chow PK, Palanisamy N, et al. Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma. J Hepatol 2008;49:52-60.
34. Teachey DT, Obzut DA, Axsom K, et al. Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS). Blood 2006;108:1965-71.
35. Twig G, Elorza A, Molina AJA, et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J 2008;27:433-46.
36. Perry DJ, Yin Y, Telarico T, et al. Murine Lupus Susceptibility Locus Sle1c2 Mediates CD4+ T Cell Activation and Maps to Estrogen-Related Receptor gamma. J Immunol 2012;189:793-803.
37. Nagy G, Koncz A, Perl A. T cell activation-induced mitochondrial hyperpolarization is mediated by Ca2+- and redox-dependent production of nitric oxide. J Immunol 2003;171:5188-97.
38. Baixauli F, Martin-Cofreces NB, Morlino G, et al. The mitochondrial fission factor dynamin-related protein 1 modulates T-cell receptor signalling at the immune synapse. EMBO J 2011;30:1238-50.
39. Delgoffe GM, Pollizzi KN, Waickman AT, et al. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat Immunol 2011;12:295-304.
40. Georgescu L, Vakkalanka RK, Elkon KB, et al. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand. J Clin Invest 1997;100:2622-33.
41. Gergely PJ, Niland B, Gonchoroff N, et al. Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus. J Immunol 2002;169:1092-101.
42. Sharif MN, Tassiulas I, Hu Y, et al. IFN-alpha priming results in a gain of proinflammatory function by IL-10: implications for systemic lupus erythematosus pathogenesis. J Immunol 2004;172:6476-81.